154 related articles for article (PubMed ID: 33406123)
1. Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.
Nonaka M; Mabashi-Asazuma H; Jarvis DL; Yamasaki K; Akama TO; Nagaoka M; Sasai T; Kimura-Takagi I; Suwa Y; Yaegashi T; Huang CT; Nishizawa-Harada C; Fukuda MN
PLoS One; 2021; 16(1):e0241157. PubMed ID: 33406123
[TBL] [Abstract][Full Text] [Related]
2. Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.
Hatakeyama S; Sugihara K; Shibata TK; Nakayama J; Akama TO; Tamura N; Wong SM; Bobkov AA; Takano Y; Ohyama C; Fukuda M; Fukuda MN
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19587-92. PubMed ID: 22114188
[TBL] [Abstract][Full Text] [Related]
3. Tumor vasculature-targeted
Yoneyama T; Hatakeyama S; Sutoh Yoneyama M; Yoshiya T; Uemura T; Ishizu T; Suzuki M; Hachinohe S; Ishiyama S; Nonaka M; Fukuda MN; Ohyama C
BMC Cancer; 2021 Jan; 21(1):72. PubMed ID: 33446132
[TBL] [Abstract][Full Text] [Related]
4. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
[TBL] [Abstract][Full Text] [Related]
5. Tumor targeting by a carbohydrate ligand-mimicking peptide.
Hatakeyama S; Shibata TK; Tobisawa Y; Ohyama C; Sugihara K; Fukuda MN
Methods Mol Biol; 2013; 1022():369-86. PubMed ID: 23765676
[TBL] [Abstract][Full Text] [Related]
6. Retro-inverso carbohydrate mimetic peptides with annexin1-binding selectivity, are stable in vivo, and target tumor vasculature.
Chen X; Fan Z; Chen Y; Fang X; Sha X
PLoS One; 2013; 8(12):e80390. PubMed ID: 24312470
[TBL] [Abstract][Full Text] [Related]
7. A d-Peptide Ligand of Integrins for Simultaneously Targeting Angiogenic Blood Vasculature and Glioma Cells.
Ren Y; Zhan C; Gao J; Zhang M; Wei X; Ying M; Liu Z; Lu W
Mol Pharm; 2018 Feb; 15(2):592-601. PubMed ID: 29283582
[TBL] [Abstract][Full Text] [Related]
8. Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.
Al-Hilal TA; Chung SW; Choi JU; Alam F; Park J; Kim SW; Kim SY; Ahsan F; Kim IS; Byun Y
J Clin Invest; 2016 Apr; 126(4):1251-66. PubMed ID: 26950422
[TBL] [Abstract][Full Text] [Related]
9. Identification and Characterization of Homing Peptides Using In Vivo Peptide Phage Display.
Hyvönen M; Laakkonen P
Methods Mol Biol; 2015; 1324():205-22. PubMed ID: 26202272
[TBL] [Abstract][Full Text] [Related]
10. Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours.
Nonaka M; Suzuki-Anekoji M; Nakayama J; Mabashi-Asazuma H; Jarvis DL; Yeh JC; Yamasaki K; Akama TO; Huang CT; Campos AR; Nagaoka M; Sasai T; Kimura-Takagi I; Suwa Y; Yaegashi T; Shibata TK; Sugihara K; Nishizawa-Harada C; Fukuda M; Fukuda MN
Br J Cancer; 2020 Nov; 123(11):1633-1643. PubMed ID: 32921792
[TBL] [Abstract][Full Text] [Related]
11. A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo.
Al-Ali HN; Crichton SJ; Fabian C; Pepper C; Butcher DR; Dempsey FC; Parris CN
Oncogene; 2024 Feb; 43(8):608-614. PubMed ID: 38200229
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography imaging of a novel Anxa1-targeted peptide
Chen F; Xiao Y; Shao K; Zhu B; Jiang M
J Labelled Comp Radiopharm; 2020 Oct; 63(12):494-501. PubMed ID: 32562502
[TBL] [Abstract][Full Text] [Related]
13. ANXA1 Binds and Stabilizes EphA2 to Promote Nasopharyngeal Carcinoma Growth and Metastasis.
Feng J; Lu SS; Xiao T; Huang W; Yi H; Zhu W; Fan S; Feng XP; Li JY; Yu ZZ; Gao S; Nie GH; Tang YY; Xiao ZQ
Cancer Res; 2020 Oct; 80(20):4386-4398. PubMed ID: 32737118
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo.
Jia C; Kong D; Guo Y; Li L; Quan L
Biochem Biophys Res Commun; 2018 Nov; 505(3):720-725. PubMed ID: 30292410
[TBL] [Abstract][Full Text] [Related]
15. Construction and application of elastin like polypeptide containing IL-4 receptor targeting peptide.
Sarangthem V; Cho EA; Bae SM; Singh TD; Kim SJ; Kim S; Jeon WB; Lee BH; Park RW
PLoS One; 2013; 8(12):e81891. PubMed ID: 24339977
[TBL] [Abstract][Full Text] [Related]
16. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo.
Zhang Z; Huang L; Zhao W; Rigas B
Cancer Res; 2010 Mar; 70(6):2379-88. PubMed ID: 20215502
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors.
Chang DK; Chiu CY; Kuo SY; Lin WC; Lo A; Wang YP; Li PC; Wu HC
J Biol Chem; 2009 May; 284(19):12905-16. PubMed ID: 19276080
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo.
Vecchi L; Alves Pereira Zóia M; Goss Santos T; de Oliveira Beserra A; Colaço Ramos CM; França Matias Colombo B; Paiva Maia YC; Piana de Andrade V; Teixeira Soares Mota S; Gonçalves de Araújo T; Van Petten de Vasconcelos Azevedo F; Soares FA; Oliani SM; Goulart LR
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1368-1382. PubMed ID: 29932988
[TBL] [Abstract][Full Text] [Related]
19. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
[TBL] [Abstract][Full Text] [Related]
20. A novel vascular-targeting peptide for gastric cancer delivers low-dose TNFα to normalize the blood vessels and improve the anti-cancer efficiency of 5-fluorouracil.
Lu L; Li ZJ; Li LF; Shen J; Zhang L; Li MX; Xiao ZG; Wang JH; Cho CH
Peptides; 2017 Nov; 97():54-63. PubMed ID: 28970092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
